Vascular endothelial growth factor

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis.
• Dysregulation of VEGF is implicated in diseases like cancer and macular degeneration.
• VEGF inhibitors are FDA-approved for treating advanced cancers and neovascular age-related macular degeneration.

Observation:

• The discovery of VEGF involved overcoming significant scientific hurdles.
• Early research focused on understanding VEGF's fundamental role in blood vessel development.
• Elucidating VEGF's function was critical for therapeutic advancements.

Findings:

• VEGF's pivotal role in both normal and abnormal angiogenesis is well-established.
• The identification of VEGF paved the way for targeted therapies.
• Understanding VEGF's regulatory mechanisms is essential for disease treatment.

Implications:

• The discovery of VEGF has revolutionized the treatment of angiogenesis-driven diseases.
• Further research into VEGF pathways may yield novel therapeutic strategies.
• Targeting VEGF remains a cornerstone in oncology and ophthalmology.